April 10, 2013
Diagnostics firm Cancer Genetics goes public
Cancer Genetics, a diagnostics firm focused on developing genomic-based oncology tests, made its initial public offering at a time of rapid growth in the diagnostic testing market. The 50/50 venture has not been formally established but both organizations have agreed to its development, a Mayo spokesman said. Cancer Genetics will provide capital investments and Mayo will […]
Tags: Cancer Genetics, diagnostics, Dr. Gianrico Farrugia, Individualized medicine, Mayo Clinc's Center for Individualized Medicine, Modern Healthcare, oncology tests